Advertisement

Older patients' experiences following initial diagnosis of acute myeloid leukemia: A qualitative study

Published:September 02, 2022DOI:https://doi.org/10.1016/j.jgo.2022.08.017

      Abstract

      Introduction

      The onset of symptoms and the diagnosis of acute myeloid leukemia (AML) often occur suddenly and may lead to a range of emotional responses. Understanding patients' experiences and emotional states allows clinicians to tailor care to patients' needs. Previous studies have largely focused on patients' experiences at diagnosis and after remission has been achieved among those who received intensive chemotherapy. In this study, we evaluated experiences of older patients with AML who had received or were receiving treatments of varying intensity, in both outpatient and inpatient settings, and who were at different stages in their treatment course at the time of our interviews.

      Materials and methods

      We conducted a single center qualitative study which aimed to understand factors influencing older patients' treatment decision-making and the findings were previously reported. This analysis specifically explored older patients' experiences at various stages after AML diagnosis. We purposively sampled patients based on treatment intensity and stage of treatment (undergoing induction treatment, post-remission treatment, or post-allogeneic hematopoietic stem cell transplant). We recruited fifteen patients aged ≥60 years with AML. The sample size was determined based on reaching data saturation for the primary study aim. For this analysis, data saturation was reached by the fourteenth manuscript. In-depth semi-structured interviews that had been recorded and transcribed were re-analyzed using inductive thematic analysis to explore patients' experiences. Coding was performed using Atlas.ti. We identified themes with the aim of capturing the most commonly shared experiences.

      Results

      Mean age of the fifteen patients was 72.1 years; all had received one or more treatments including intensive induction therapy (10/15), lower-intensity treatment (7/15), and/or hematopoietic stem cell transplant (3/15). Patients experienced strong negative emotional responses, including shock, that were barriers to processing information and meaningful communication. Patients also shared their perspectives on communication with healthcare professionals (including thoughts on adequacy of information provided) and coping strategies.

      Discussion

      Understanding older patients' experiences, including emotional responses and barriers to communication and decision making, at AML diagnosis and throughout the illness trajectory allows clinicians to address patients' supportive care needs during this difficult period.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Geriatric Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Acute Myeloid Leukemia - Cancer Stat Facts. SEER. Accessed April 4, 2021. https://seer.cancer.gov/statfacts/html/amyl.html.

        • Abdallah M.
        • Xie Z.
        • Ready A.
        • Manogna D.
        • Mendler J.H.
        • Loh K.P.
        Management of Acute Myeloid Leukemia (AML) in older patients.
        Curr Oncol Rep. 2020; 22: 103https://doi.org/10.1007/s11912-020-00964-1
        • El-Jawahri A.
        • Nelson-Lowe M.
        • VanDusen H.
        • et al.
        Patient-clinician discordance in perceptions of treatment risks and benefits in older patients with acute myeloid leukemia.
        Oncologist. 2019; 24: 247-254https://doi.org/10.1634/theoncologist.2018-0317
        • LeBlanc T.W.
        • Fish L.J.
        • Bloom C.T.
        • et al.
        Patient experiences of acute myeloid leukemia: a qualitative study about diagnosis, illness understanding, and treatment decision-making.
        Psychooncology. 2017; 26: 2063-2068https://doi.org/10.1002/pon.4309
        • Sekeres M.A.
        • Gerds A.T.
        Mitigating fear and loathing in managing acute myeloid leukemia.
        Semin Hematol. 2015; 52: 249-255https://doi.org/10.1053/j.seminhematol.2015.03.009
        • Nissim R.
        • Zimmermann C.
        • Minden M.
        • et al.
        Abducted by the illness: a qualitative study of traumatic stress in individuals with acute leukemia.
        Leuk Res. 2013; 37: 496-502https://doi.org/10.1016/j.leukres.2012.12.007
        • Ghodraty-Jabloo V.
        • Alibhai S.M.H.
        • Breunis H.
        • Puts M.T.E.
        One day at a time: improving the patient experience during and after intensive chemotherapy for younger and older AML patients.
        Leuk Res. 2015; 39: 192-197https://doi.org/10.1016/j.leukres.2014.11.028
        • Ghodraty-Jabloo V.
        • Alibhai S.M.H.
        • Breunis H.
        • Puts M.T.E.
        Keep your mind off negative things: coping with long-term effects of acute myeloid leukemia (AML).
        Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2016; 24: 2035-2045https://doi.org/10.1007/s00520-015-3002-4
        • Mazzocco K.
        • Masiero M.
        • Carriero M.C.
        • Pravettoni G.
        The role of emotions in cancer patients’ decision-making.
        ecancermedicalscience. 2019; 13914https://doi.org/10.3332/ecancer.2019.914
        • Nold R.J.
        • Beamer R.L.
        • Helmer S.D.
        • McBoyle M.F.
        Factors influencing a woman’s choice to undergo breast-conserving surgery versus modified radical mastectomy.
        Am J Surg. 2000; 180: 413-418https://doi.org/10.1016/s0002-9610(00)00501-8
        • Quinn G.P.
        • Koskan A.
        • Wells K.J.
        • et al.
        Cancer patients’ fears related to clinical trial participation: a qualitative study.
        J Cancer Educ Off J Am Assoc Cancer Educ. 2012; 27: 257-262https://doi.org/10.1007/s13187-012-0310-y
        • Loh K.P.
        • Abdallah M.
        • Kadambi S.
        • et al.
        Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists.
        Leuk Lymphoma. 2020; : 1-12https://doi.org/10.1080/10428194.2020.1832662
        • Peditto K.
        Reporting qualitative research: standards, challenges, and implications for health design.
        HERD Health Environ Res Des J. 2018; 11: 16-19https://doi.org/10.1177/1937586718772615
        • Tong A.
        • Sainsbury P.
        • Craig J.
        Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.
        Int J Qual Health Care. 2007; 19: 349-357https://doi.org/10.1093/intqhc/mzm042
        • Chircop D.
        • Scerri J.
        Being diagnosed with cancer: the experiences of patients with non-Hodgkin’s lymphoma.
        J Clin Nurs. 2017; 26: 4899-4904https://doi.org/10.1111/jocn.13967
        • Scheibe S.
        • Carstensen L.L.
        Emotional aging: recent findings and future trends.
        J Gerontol B Psychol Sci Soc Sci. 2010; 65B: 135-144https://doi.org/10.1093/geronb/gbp132
        • Pinquart M.
        • Duberstein P.R.
        Information needs and decision-making processes in older cancer patients.
        Crit Rev Oncol Hematol. 2004; 51: 69-80https://doi.org/10.1016/j.critrevonc.2004.04.002
        • Friis L.S.
        • Elverdam B.
        • Schmidt K.G.
        The patient’s perspective: a qualitative study of acute myeloid leukaemia patients’ need for information and their information-seeking behaviour.
        Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2003; 11: 162-170https://doi.org/10.1007/s00520-002-0424-6
        • Finney Rutten L.J.
        • Agunwamba A.A.
        • Wilson P.
        • et al.
        Cancer-related information seeking among cancer survivors: trends over a decade (2003−2013).
        J Cancer Educ Off J Am Assoc Cancer Educ. 2016; 31: 348-357https://doi.org/10.1007/s13187-015-0802-7
        • Loh K.P.
        • Tsang M.
        • LeBlanc T.W.
        • et al.
        Decisional involvement and information preferences of patients with hematologic malignancies.
        Blood Adv. 2020; 4: 5492-5500https://doi.org/10.1182/bloodadvances.2020003044
        • Burd A.
        • Levine R.L.
        • Ruppert A.S.
        • et al.
        Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the beat AML master trial.
        Nat Med. 2020; 26: 1852-1858https://doi.org/10.1038/s41591-020-1089-8
        • Epstein R.M.
        Facing epistemic and complex uncertainty in serious illness: the role of mindfulness and shared mind.
        Patient Educ Couns. 2021; 104: 2635-2642https://doi.org/10.1016/j.pec.2021.07.030
        • Greer J.A.
        • Jacobs J.M.
        • El-Jawahri A.
        • et al.
        Role of patient coping strategies in understanding the effects of early palliative care on quality of life and mood.
        J Clin Oncol. 2018; 36: 53-60https://doi.org/10.1200/JCO.2017.73.7221
      2. Coping Strategies in Patients with Acute Myeloid Leukemia|Blood Advances. American Society of Hematology. Accessed January 16, 2022. doi:https://doi.org/10.1182/bloodadvances.2021005845/477961.

      3. You Want to Measure Coping but Your Protocol's too Long: Consider the Brief COPE - PubMed.
        (Accessed January 16, 2022)
        • El-Jawahri A.
        • LeBlanc T.W.
        • Kavanaugh A.
        • et al.
        Effectiveness of integrated palliative and oncology care for patients with Acute Myeloid Leukemia: a randomized clinical trial.
        JAMA Oncol. 2021; 7: 238-245https://doi.org/10.1001/jamaoncol.2020.6343
        • Kurtin S.
        Interdisciplinary Management of Acute Leukemia across the continuum of care.
        Semin Oncol Nurs. 2019; 35150953https://doi.org/10.1016/j.soncn.2019.150953
        • Carver C.S.
        • Scheier M.F.
        • Weintraub J.K.
        Assessing coping strategies: a theoretically based approach.
        J Pers Soc Psychol. 1989; 56: 267-283https://doi.org/10.1037//0022-3514.56.2.267
        • Mannis G.
        The Feasibility of Telehealth-Based Palliative Care Intervention and Digital Symptom Monitoring on Patients With AML Receiving Low-Intensity Induction Therapy.
        (Accessed September 28, 2021)
        • Nørskov K.H.
        • Overgaard D.
        • Boesen J.
        • et al.
        Patient ambassador support in newly diagnosed patients with acute leukemia during treatment: a feasibility study.
        Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2021; 29: 3077-3089https://doi.org/10.1007/s00520-020-05819-w
        • Röllig C.
        • Kramer M.
        • Schliemann C.
        • et al.
        Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?.
        Blood. 2020; 136: 823-830https://doi.org/10.1182/blood.2019004583